Valuation: MRI Interventions Inc

Market Cap 45Cr 40Cr 37Cr 34Cr 64Cr 4.37TCr 65Cr 440.39Cr 171.77Cr 2.13TCr 169.22Cr 165.56Cr 7.39TCr P/E 2026 *
-13.5x
P/E 2027 * -16x
Enterprise Value 45Cr 40Cr 37Cr 34Cr 64Cr 4.37TCr 65Cr 440.39Cr 171.77Cr 2.13TCr 169.22Cr 165.56Cr 7.39TCr EV / Sales 2026 *
8.48x
EV / Sales 2027 * 7.03x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 07/11/2017
Director of Finance/CFO 41 01/01/2021
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 68 10/03/2014
Chairman 80 04/02/2021
Director/Board Member 49 07/11/2017
Change 5-day change 1-year change 3-year change Capi.($)
+24.88%-8.05% - - 45Cr
+8.71%+5.36%+22.63%+0.14% 20TCr
+7.46%-6.10%-2.72%-25.38% 13TCr
-2.54%-17.48%-33.85%+2.61% 12TCr
+1.42%-2.33%-59.56%-16.47% 6.39TCr
-0.65%-4.58%+8.98%-8.29% 4.86TCr
-1.56%-2.07%-25.50%-33.72% 4.39TCr
+4.71%+2.67%+16.97%+9.41% 3.77TCr
+3.13%+1.12%+29.35%+33.26% 3.64TCr
+3.14%+3.47%+88.18%+4.67% 2.89TCr
Average +4.49%-3.39%+4.94%-3.75% 7.79TCr
Weighted average by Cap. +3.57%-4.99%-0.32%-5.83%

Financials

2026 *2027 *
Net sales 5.31Cr 4.67Cr 4.34Cr 3.99Cr 7.49Cr 514.55Cr 7.62Cr 52Cr 20Cr 250.98Cr 20Cr 20Cr 870.71Cr 6.41Cr 5.64Cr 5.24Cr 4.82Cr 9.03Cr 620.76Cr 9.2Cr 63Cr 24Cr 302.78Cr 24Cr 24Cr 1.05TCr
Net income -3.31Cr -2.91Cr -2.7Cr -2.48Cr -4.66Cr -320.22Cr -4.74Cr -32Cr -13Cr -156.19Cr -12Cr -12Cr -541.87Cr -2.86Cr -2.52Cr -2.34Cr -2.15Cr -4.04Cr -277.29Cr -4.11Cr -28Cr -11Cr -135.25Cr -11Cr -11Cr -469.22Cr
Net Debt - -
Logo MRI Interventions Inc
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-